CA Patent

CA2516836A1 — Methods of tangential flow filtration and an apparatus therefore

Assigned to rEVO Biologics Inc · Expires 2004-09-10 · 22y expired

What this patent protects

Processes and apparati are provided for separating molecules of interest fro m a mixture containing them which comprises subjecting the mixture to an improved method of tangential flow filtration (TFF). The improved TFF was us ed to clarify, and process various feedstreams for th…

USPTO Abstract

Processes and apparati are provided for separating molecules of interest fro m a mixture containing them which comprises subjecting the mixture to an improved method of tangential flow filtration (TFF). The improved TFF was us ed to clarify, and process various feedstreams for the removal of a molecule of interest. According to a preferred embodiment, a transgenic milk feedstream is stabilized and particulate matter such as fat, casein miscelles and bacteria are removed. The method of TFF used in the current invention utilizes optimized process parameters that include temperature, transmembrane pressur e, cross-flow velocity, and milk concentration. Cleaning and storage procedures were also developed to ensure long membrane life. An aseptic filtration step was also developed to remove any bacteria remaining in a clarified transgeni c milk feedstream.

Drugs covered by this patent

Patent Metadata

Patent number
CA2516836A1
Jurisdiction
CA
Classification
Expires
2004-09-10
Drug substance claim
No
Drug product claim
No
Assignee
rEVO Biologics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.